✦ LIBER ✦

An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists

✍ Scribed by Michael Koch; Christopher Steidle; Stanley Brosman; Arthur Centeno; Franklin Gaylis; Marilyn Campion; Marc B Garnick

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 3, multicenter, open-label, rand

✍ David McLeod; Norman Zinner; Kevin Tomera; Donald Gleason; Nick Fotheringham; Ma 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 120 KB

442 Marked loss of LH bioactivity in men

✍ R. St-Arnaud; S. Kelly; A. Dupont; A. Belanger; F. Labrie 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Pituitary desensitization and loss of lu

✍ R. St-Arnaud; R. Lachance; A. Bélanger; A. Dupont; F. Labrie 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 84 KB

A study from the EORTC new drug developm

✍ W. Fiedler; N. Tchen; J. Bloch; P. Fargeot; R. Sorio; J.B. Vermorken; L. Collett 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Effect of Discontinuation of Tamsulosin

✍ Joo Yong LEE; Dong Hyuk KANG; Sung Yul PARK; Seung Wook LEE; Yong Tae KIM; Hong 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 606 KB

Treatment with curative intent and survi

✍ Sam Ladjevardi; Anders Berglund; Eberhard Varenhorst; Ola Bratt; Anders Widmark; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB